MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy

Gynecologic Oncology

Volumn 110, Issue 3, 2008, Pages 304-307

  Lloret, Marta ^a,b,d   Lara, Pedro Carlos ^a,b,d   Bordón, Elisa ^b,d   Rey, Agustin ^a,b,d   Falcón, Orlando ^b,c,d   Apolinario, Rosa Maria ^b,d   Clavo, Bernardino ^a,b,d   Ruiz, Ana ^a,b,d  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b Facultad de Ciencias Farmacéuticas y Bioquímicas   (Spain)

^c HOSPITAL UNIVERSITARIO MATERNO INFANTIL DE CANARIAS   (Spain)

^d HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Cervix carcinoma; IGF 1R; MVP; Radiochemotherapy

Indexed keywords

CISPLATIN; LUNG RESISTANCE PROTEIN; PARAFFIN; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTOR, IGF TYPE 1; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 50149106728     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.034     Document Type: Article

References (15)

1. Kickhoefer V.A., Siva A.C., Kedersha N.L., et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 146 (1999) 917-928
2. Mossink M.H., van Zon A., Scheper R.J., Sonneveld P., and Wiemer E.A. Vaults: a ribonucleoprotein particle involved in drug resistance?. Oncogene 22 47 (2003) 7458-7467
3. Izquierdo M.A., Scheffer G.L., Flens M.J., et al. Broad distribution of the multidrug resistance -related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 148 3 (1996) 877-887
4. Steiner E., Holzmann K., Elbling L., Micksche M., and Berger W. Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 8 (2006) 923-934
5. Minaguchi T., Waite K.A., and Eng C. Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein. Cancer Res 66 24 (2006) 11677-11682
6. Xiang Z., Yuan W., Luo N., et al. A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway. Biochem Biophys Res Commun. 347 1 (2006) 288-296
7. Kim E., Lee S., Mian M.F., et al. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. FEBS J. 273 4 (2006) 793-804
8. Fichtner I., Paal K., Borgmann A., Badiali L., Wurm R., and Henze G. Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias-correlation to the expression of multidrug resistance proteins. Anticancer Res 23 3B (2003) 2657-2664
9. Yi C., Li S., Chen X., et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res 65 13 (2005) 5835-5840
10. Dornan D., Shimizu H., Mah A., et al. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 313 5790 (2006) 1122-1126
11. Silva P., West C.M., Slevin N., et al. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma. Int J Radiat Oncol BiolPhys 69 1 (2007) 133-140
12. Baserga R., Peruzzi F., and Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 107 6 (2003) 873-877
13. Lloret M., Lara P.C., Bordón E., et al. IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy. Gynecol Oncol. 106 1 (2007) 8-11
14. Cervix uteri. In: Greene F.L., Page D.L., Flemming I.D., et al. (Eds). American Joint Committee on Cancer: AJCC cancer staging manual. 6th ed. (2002), Springer, New York, NY 259-265
15. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 3 (2000) 205-216